Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging

Authors not listed

Huashan Hospital · 2023

Abstract

To explore the diagnostic value of \[18F\]CSF-23 brain imaging for CSF1R expression in Alzheimer's disease. PET imaging with this PET tracer was used to assess the role and expression of CSF1R in AD and to evaluate the level and safety of abnormal present imaging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Anonymous. (2023). CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging. <em>Huashan Hospital</em>. https://clinicaltrials.gov/study/NCT06148233
Vancouver
Anonymous. CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging. Huashan Hospital. 2023.
BibTeX
@misc{anon2023CSFRPE, title = {CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging}, author = {Anonymous}, journal = {Huashan Hospital}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings